Intervention group:Anlotinib

3 trials

Sponsors

Shanghai Pulmonary Hospital, People's Hospital Affiliated to Hubei University of Medicine, the First Affiliated Hospital of Zhejiang University School of Medicine

Conditions

GlioblastomaLung Canceresophageal cancer

Phase 1

Exploratory Study of Anlotinib Combined with STUPP Regimen in the Treatment of Glioblastoma Post Partial Resection or Biopsy

Active, not recruitingChiCTR2400086281

the First Affiliated Hospital of Zhejiang University School of MedicineGlioblastoma

Start: 2024-07-01Updated: 2024-07-08

Phase 2

Phase II Clinical Trial of Adjuvant Anlotinib in Patients with Stage IA Non-Small Cell Lung Cancer at High Risk of Recurrence

RecruitingChiCTR2000037398

Shanghai Pulmonary HospitalLung Cancer

Start: 2020-09-01Updated: 2020-10-19

Phase 4

A single-arm, prospective, single-center clinical study of Anlotinib hydrochloride capsules for maintenance therapy after radical concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma

RecruitingChiCTR2100053579

People's Hospital Affiliated to Hubei University of Medicineesophageal cancer

Start: 2021-12-01Updated: 2022-10-17